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Bayesian modelSequence tag count-based gene expression analysis is potent for the identiﬁcation of candidate genes
relevant to the cancerous phenotype. With the public availability of count-based data, the computational
approaches for differentially expressed genes, which are mainly based on Binomial or beta-Binomial
distribution, become practical and important in cancer biology. It remains a permanent need to select a
proper statistical model for these methods. In this study, we developed a novel Bayesian algorithm-based
method, Electronic Differential Gene Expression Screener (EDGES), in which a statistical model was
determined by geometric averaging of 12 common housekeeping genes. EDGES identiﬁed a set of
differentially expressed genes in lung, breast and colorectal cancers by using publically available Serial
Analysis of Gene Expression (SAGE) and Expressed Sequence Tag (EST data). Gene expression microarray
analysis and quantitative reverse transcription real-time PCR demonstrated the effectiveness of this
procedure. We conclude that current normalization of calibrators provides a new insight into count-based
digital subtraction in cancer research.© 2009 Elsevier Inc. All rights reserved.IntroductionIn cancer genome research, it remains a permanent need to
discover differentially expressed genes in clinical samples from cancer,
precancerous lesions or cancers with different phenotypes. These
candidate genes not only provide critical clues to understand the
molecular mechanism of cancer initiation and progression, but also
contribute to identiﬁcation of potential biomarkers for cancer
prevention, diagnosis, and intervention [1–3].
Currently, investigation of differentially expressed genes in cancer
is generally in a whole genome manner. The range of technologies
used in this ﬁeld can be categorized into two types: gene expression
microarrays (signal intensity-based) and sequence tag library (count-
based) approaches. The library approaches are characterized by two
main methods: Expressed Sequence Tag (EST) and Serial Analysis of
Gene Expression (SAGE) [4,5]. However, a library is only a snapshot of
the mRNA composition of a speciﬁc tissue at a speciﬁc time because at
least 10,000 different genes are expressed in a cell with an average of
about 30,000 mRNA molecules per cell. The computational approach
for mining differentially expressed genes from EST or SAGE library
pools may give new insights into our global understanding towardsn, the ﬁrst two authors should
ll rights reserved.cancer initiation and progression and have been showing its
importance increasingly [6–10].
Many computational methods were developed to detect differen-
tially expressed genes among various libraries by using a simple fold-
change criterion [11], a Fisher exact test [9,12,13], Bayesian models
[6,14–16], a beta-Binomial hierarchical model [17], a logistic regres-
sion model [18] and a Poisson mixed model [19]. Many methods tried
to solve the problem of multiple variations that were associated with
size differences between different tissue pools [6,9,11–19]. Most
procedures are essentially based on the same Binomial or beta-
Binomial distribution. A hidden problem in these approaches is that
some inconsistency inevitably occurs if the Binomial distribution is
not an optimal model for unknown biological processes such as
cancer. Hence, it is a pressing need to ﬁnd new approach to select a
proper statistical model.
Internal control genes – often referred to as housekeeping genes –
are most frequently used to normalize the mRNA fraction in gene
expression analysis among samples, such as real-time reverse
transcription PCR, northern blotting and gene expression microarray.
Likewise, we hypothesize that these control genes might be appro-
priate for statistical model selection in digital gene expression
analysis. Prompted by this, we here propose a Bayesian algorithm-
based approach, Electronic Differential Gene Expression Screener
(EDGES), in which the minimal fold change for selecting candidate
genes and the statistical model are determined by common house-
keeping genes. By analyzing both EST and SAGE data from a variety of
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appropriate in digital differential gene expression analysis.
Results
Statistical model selection in EDGES
The choice of parameter c and F is paramount in the Binomial
distribution. c, a constant for a given speciﬁc mRNA, is proportional to
the overall probability of x. The more appropriate c suggests a greater
concentration of x near 0.5. The larger the c value is, the more
observed evidences are required to infer a signiﬁcant change of
expression level for a speciﬁc transcript by a given factor. The value of
F directly deﬁnes the minimal signiﬁcant fold change for the transcript
in two libraries given the distribution of prior probability density.
Generally, the combination of c and F value determines the screening
performance of Binomial distribution model (see the Methods
section). However, these values were primarily set on the basis of
experimental feedback and experience in previous studies [6,14]. Thus
they might be arbitrary and unsuitable when there was a big size
difference between pools which contain multiple biological duplicates.
We tried to solve this problem by using 12 common housekeeping
genes for normalization in EDGES procedure (Table 1). These genes
belong to different functional analysis, which reduces the chance that
genes might be co-regulated. Geometric averaging of these genes
showed accurate mRNA normalization in quantitative RT-PCR pre-
viously [20]. Guided by the protocols in themethod section (Fig.1), we
identiﬁed the c and F values for each housekeeping gene in the
normal-cancer paired library pool. The ﬁnal c and F values for
normalization were determined by geometric averaging of these
internal control genes (Table 1).
Identiﬁcation and validation of differentially expressed genes in various
cancers by EDGES
In comparison of SAGE libraries between cancer and normal tissue,
our EDGES procedure with housekeeping gene normalized statistical
model identiﬁed a total of 275 differentially expressed genes in lung,
58 in breast, and 203 in colorectum. Additional 215 and 21 candidate
genes also showed differential expression in colorectal cancer and
adenoma EST pools. The details of these candidate genes were given in
supplementary data S1.Table 1
Determination of c and F values in the statistics model by housekeeping genes.
Breast (SAGE) Lung (SAGE) Full gene name Accessio
numberF↓ c↓ F↑ c↑ F↓ c↓ F↑ c↑
3 3 2 3.5 2 1 4 1 β-Actin NM_001
NA NA NA NA 2 1 2 1 Beta-2-microglobulin NM_004
3 3 2 3.5 2 1 3 4 Glyceraldehyde-3-phosphate
dehydrogenase
NM_002
NA NA NA NA 3 3.5 2 3.5 Hydroxymethyl-bilane synthase NM_000
NA NA NA NA 4 3.5 2 1 Hypoxanthine phosphoribosyl-
transferase 1
NM_000
3 3 2 3.5 2 1 3 5 Ribosomal protein L13a NM_012
2 1 4 1 2 1 4 4 Ribosomal protein L32 NM_000
2 1 3 2.5 3 1 2 1 Ribosomal protein S18 NM_022
2 1 3 3.5 4 3.5 2 1 Succinate dehydrogenase
complex, subunit A
NM_004
3 4.5 2 1 3 3.5 2 3.5 TATA box binding protein NM_003
3 4.5 2 1 3 4 2 1 Ubiquitin C M26880
4 3.5 2 1 2 1 3 4.5 Tyrosine 3-monooxygenase/
tryptophan 5-monooxygenase
activation protein, zeta
polypeptide
NM_003
2.71 2.32 2.36 1.93 2.57 1.7 2.48 2.01
¶Abbreviations: N = normal; A = adenoma; T = cancer; GA = geometric average.
“↑” refers as to T (or A) versus N comparison and “↓” vice versa.We believe that a candidate gene is more likely to be differentially
expressed in speciﬁc samples if it is identiﬁed by two or more
methods. Therefore, we suggested gene expression microarray to
assess the efﬁciency of our EDGES method. Differentially expressed
genes detected by using BRB Array Tools in cancers were shown in
supplementary data S2. Microarray validated 32.4% (89/275) and
41.4% (24/58) candidates from cancer versus normal SAGE pools in
lung and breast, separately. The overlap between candidates from
microarray and EDGES analysis seemed to be lower in colorectal
normal versus cancer SAGE pools (24/203, 11.8%) or EST pools (22/
215, 10.2%) although the overlap was good in colorectal normal versus
adenoma pools (5/21, 23.8%) that had the biggest unequal aggregate
numbers of tags (nearly 20 folds of size difference). This low cover rate
in colorectal cancer might partially be associated with the sequence
quality of these electronic libraries or simply the poor quality of the
microarray dataset for colorectal cancer as results for adenoma look
good. We also found that only 3 candidate genes in colorectal cancer
were all screened by SAGE-EDGES, EST-EDGES and microarray. Some
important tumor suppressor genes or oncogenes including APC
(adenomatous polyposis coli, NM_000038), TP53 (tumor protein
p53, NM_000546), DCC (deleted in colorectal carcinoma,
NM_005215), SMAD4 (SMAD family member 4, NM_005359), BRCA1
(breast cancer 1, early onset, NM_007294), KRAS (v-Ki-ras2 Kirsten rat
sarcoma viral oncogene homolog, NM_004985), EGFR [epidermal
growth factor receptor (erythroblastic leukemia viral (v-erb-b)
oncogene homolog, avian), NM_005228] and BRAF (v-raf murine
sarcoma viral oncogene homolog B1, NM_004333) are not present in
all the current transcriptome studies on various cancers.We think that
the molecular heterogeneity of cancers, the potential defects of
current global gene expression methods, the molecular heterogeneity
of colorectal cancers and the bias of data themselves are major
contributing factors. Meanwhile, some genes, such as APC, p53, k-ras
and BRAF, are well-known to be associated with gene mutations
rather than the alterations at mRNA level. Hence, a comprehensive
characterization of transcriptome proﬁles from modern technologies
would be complimentary and improve the screening efﬁciency [21].
We ﬁnally used qRT-PCR to validate the differential expressed
genes identiﬁed by EDGES. In keeping with the results of EDGES
analysis, down-regulation of KLF4 (Kruppel-like factor 4 (gut),
NM_004235) in colorectal cancer and over-expression of REG4
(Regenerating islet-derived family, member 4, NM_032044) in color-
ectal adenomas were conﬁrmed by qRT-PCR in our previous studiesn Gene
symbol
Colorectal T(EST) Colorectal A(EST) Colorectal (SAGE)
F↓ c↓ F↑ c↑ F↓ c↓ F↑ c↑ F↓ c↓ F↑ c↑
101 ACTB 2 1 3 1 2 3 2 1 2 1 2 1
048 B2M 2 1 2 1 3 4 2 1 2 1 2 1
046 GAPD 2 1 2 1 2 1 4 4.5 2 1 3 1
190 HMBS 3 4 2 1 3 2.5 3 2.5 2 2 3 3.5
194 HPRT1 3 3 2 4 3 2.5 3 2.5 3 3.5 2 2.5
423 RPL13A 2 1 2 1 2 1 NA NA 2 1 4 1
994 RPL32 4 4.5 2 1 3 2.5 3 2.5 2 1 3 1
551 RPS18 3 5 2 1 3 2.5 3 2.5 2 1 3 1
168 SDHA 2 3.5 2 1 2 1 3 4 2 3.5 2 1
194 TBP 3 3.5 2 1 3 2.5 3 2.5 NA NA NA NA
UBC 2 1 3 1 2 1 3 1 2 1 4 4
406 YWHAZ 3 4 2 1 2 1 3 4 2 4.5 2 1
GA 2.51 2.21 2.14 1.12 2.45 1.8 2.86 2.24 2.08 1.53 2.63 1.38
Fig. 1. Parameters normalized by housekeeping genes in EDGES. The characteristic ﬁgures for c and F selectionwere exempliﬁed in SAGE and EST libraries between colorectal cancers
and normal colon (A: SAGE; B: EST). Each of the putative F value is put at the top of individual graph. The c values are shown in the X-axis and the probability of the speciﬁc c value is
present in the Y-axis. The dash line is to show the optimal c value that ensures the probability of calibrator genes at the cutoff value (0.90). We here chose the c and F combination
with lower C values as the ﬁnal parameters.
213B. Lü et al. / Genomics 94 (2009) 211–216[22,23]. Here, we further detected another candidate gene, PIGR
(polymeric immunoglobulin receptor, NM_002644), that was
detected to be down-regulated in colorectal cancer by EDGES analysis
of EST and SAGE data. We observed that expression of PIGR decreased
in 22 out of 24 cancer samples. PIGRwas signiﬁcantly down-regulated
in colorectal cancers referring to individual-matched normal samples
(2−Δ Ct mean±SD: normal 27.21±24.22, cancer 6.78±10.38;
pb0.01,Wilcoxon test; Fig. 2). Taken together, experimental validationFig. 2. Downregulation of PIGR in colorectal cancers by qRT-PCR. The relative
quantiﬁcation of PIGR expression in the y axis for individual tissue samples was calculated
as the average 2−Δ CtwhereΔ Ct=Ct-Mean Ct (GAPDH, BACT, B2M). As depicted is the down-
regulation of PIGR in 24 colorectal cancers (mean±SD: normal 27.21±24.22, cancer
6.78±10.38; pb0.01, Wilcoxon test).of these candidate genes also supported the screening efﬁciency of
current EDGES approach.
Discussion
Owing to accumulating publically available databases and
advances in bioinformatics, researchers can capture molecular
patterns of various cancers by computational approaches that
frequently utilized SAGE, EST and microarray data [5,6,9,24]. General
limitations in sequencing tag count-based digital strategies include
sequencing errors and size differences in libraries or pools. The former
are systematic and can be circumvented by improved sequencing
technique and automatic sequencing pipeline. The latter belong to
random and stochastic errors, and thus are inevitable. Great efforts
were done to correct these kinds of errors [15–19]. However, it still
needs much work to overcome these problems.
The current EDGES, which make use of housekeeping genes as
calibrators to determine c and F values, also attempted to provide an
option for this potential technical problem. The basic concept of our
EDGES procedure is based on the hypothesis that the unequal tag
aggregate numbers is due to size differences, which are associated
with the initial mRNA content and technical factors in the construc-
tion of libraries. Theoretically, total tags in the SAGE or EST pool can be
regarded as the total of mRNA molecules (absolute total mRNA
expression) in a speciﬁc tissue type and counts (i.e., tag abundance)
for mRNA expression level of a speciﬁc gene. Accurate normalization
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prerequisite for reliable results in orthogonal experiments. The
geometric averaging of multiple internal control genes showed
substantially accurate normalization in gene expression proﬁling
[20]. Presumably, this normalization concept should be also appro-
priate to determine statistics models in digital differential gene
expression analysis, for example, serving as an alternative of
determining c and F values in the current Bayesian approach.
Guided by this conception, our EDGES procedure analyzed
differentially expressed genes in various cancers by using 2 popular
count-based data, SAGE and EST. We noticed that the performance of
our EDGES was generally good as indicated by microarray validation
and qRT-PCR, particularly in the EST library of colon adenoma versus
normal that had the greatest size differences. One may postulate that
EDGES be particularly powerful in dealing with libraries of great size
variations. The bottleneck of current gene expression techniques
inevitably hampers the performance of EDGES on individual dataset.
For example, some important tumor suppressor genes, such as p16,
DCC and SMAD4, are not present in all current transcriptomic studies
(including SAGE, EST and microarray) of various cancers. Fortunately,
more reliable techniques have been emerging recently, such as long
SAGE, massively parallel signature sequencing (MPSS), absolute
mRNA quantiﬁcation by the next generation of “tag sequencing”
machine and spectral counting by non-labeled LC–MS/MS [25–28].
We believe that EDGES might be promising in future analysis of these
tag count-based data, either.
We think the current EDGES method need to be improved in
several aspects. First, a tissue speciﬁc pattern of housekeeping genes
with relatively higher abundance and more stable expression might
be better for the selection of statistical parameters for a speciﬁc tissue
type than the present 12 housekeeping genes when one considered
the distribution variations of these genes among breast, lung and
colorectum. Previous study argued an approximately 400-fold
expression difference between the most abundant and the rarest
housekeeping genes and 112-fold for a single gene in a large variety of
tissues [20]. Unfortunately, the tissue speciﬁc housekeeping genes for
normalization remain unavailable currently. Second, the two para-
meters, c and F, are continuous variables, but during the current
procedure of ﬁnding a suitable combination of c and F, we consider c
and F as discrete for calculation convenience, e.g. c=1, 1.5, 3, F=1, 2,
3, 4, etc based on the assumption that the ﬁnal results wouldn't be
affected too much between c and c+δ (δb0.5 or δb1) or between F
and F+δ (δb0.5 or δb1). Although it is impractical to try every
possible value of the parameters in reality, it would be probably more
accurate if we set them close to continuous by taking a small step size
of generating parameter values to be considered, for example, a value
of 1.68 might be more appropriate than 2 or 1.5. Finally, the statistical
model used for measuring signiﬁcance might be improved by
employing a more appropriate distribution to describe the gene
expression data than the simple beta distribution used currently.
In conclusion, the current EDGES approach is effective in screening
differentially expressed genes from count-based gene expression data.
More importantly, EDGES gives an alternative of selecting an
appropriate threshold of fold changes and proper statistical model
for signiﬁcance measurement by introducing the classical conception
of calibrators from orthogonal experiments, thus may impact on
future tag-based digital subtraction.
Methods
Electronic Differential Gene Expression Screener (EDGES)
The sampling of SAGE or EST tags can be best approached by the
Binomial distribution which describes the probability of observing a
number of successes in a series of Bernoulli trials. In this model, the
library size corresponds to the number of trials and the count of aparticular tag is the number of successful trial outcomes. Here, we also
developed amethod (EDGES) in R language (available at http://www.
zjupath.org/~jyyu/edges.htm) to detect differentially expressed
genes between sequence tag pools by using a previously described
Bayesian approach [6,14]. We assume that, in two count-based gene
expression library pools, A and B with size as A and B respectively, a
and b are the raw tag counts corresponding to a speciﬁc mRNA
transcript or a UniGene. We study the probability (p) that the fold
change of a speciﬁc gene's expression level between library A and
library B is no more than F. The value of p ranges from 0 to 1. The
smaller the p value, the more frequently a UniGene would appear in
pool A than in pool B by a factor of F, and the less likely that this
observation is associated with sampling error. Assuming that in the
two actual pool A and B, the expected concentrations of a speciﬁc gene
in these libraries are Ca and Cb, we can obtain the expected tag odds
ratio f=Ca/Cb. We deﬁne a variable x= f/(f+1), and x lies in an
uniform interval of zero to one. However, the expression levels of most
genes do not differ greatly between normal and cancerous cells [4].
Hence, the prior distribution should not be uniform but should be
peaked near 0.50. This corresponds to a beta distribution, inwhich, we
need to assume a prior probability distribution for x that will
reasonably peak at and be symmetric near 0.5 [29]. For mathematical
convenience, we assume the prior probability density f (x) of x given
by Eq. (1)
f xð Þ = C 2c + 2ð Þ
C c + 1ð Þ½ z x
c 1−xð Þc ð1Þ
where c is a positive real number and Г is the gamma function. f(x)
is a special case of beta distribution in which the two parameters
are equal, i.e. beta(c+1, c+1).Given the observed a and b copies in
library A and library B, the posterior probability density of x is beta
(c+a+1, c+b+1) if A is approximately equal to B. Under the
condition that A and B are obviously different, the posterior
probability density is derived to be proportional to a function g(x)
given by Eq. (2).
g xð Þ = x
c + a 1−xð Þc + b
1 + A
B
−1
 
x
h ia + b ð2Þ
p l1 V x V l2ð Þ = 1c
Z l2
l1
g xð Þdx ð3Þ
With g(x), we can calculate the posterior probability that f falls in
any given range as x is proportional to f, and for f in [F1, F2]. The
posterior probability is given by Eq. (3), where l1=F1/(F1+1),
l2=F2/(F2+1) and c is a constant for a given speciﬁc mRNA. C is
proportional to the overall probability of x, thus is calculated by
integrating g(x) from zero to one. So the posterior probability density
h(x) is denoted as g(x)/c. Then the value of previously deﬁned p,
which is used for evaluating statistical signiﬁcance for a given factor F,
is calculated by integrating h(x) from 0 to F/(F+1).
The c and F values were previously set on the basis of experimental
feedback and experience [6,14]. Thus they might be arbitrary and
unsuitable when there was a big size difference between pools which
contain multiple biological duplicates. The expression of house-
keeping genes is universal and relatively constant in most cells
under various conditions. Therefore, they remain the mainstay for the
mRNA fraction calibration in nearly all modern mRNA expression
experiments including real-time reverse transcription PCR, northern
blotting and gene expression microarray despite the variable expres-
sion of a single housekeeping gene between samples might exist.
Great efforts were taken for a single deﬁnite reference gene recently
[30,31]. However, none is unequivocally accepted as a gold-standard
gene for normalization. Currently, the mean expression of multiple
housekeeping genes was believed to be the best alternative for
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keeping genes can be used to calibrate measurements by setting
proper c and F values in digital gene expression analysis. Theoretically,
a prior probability distribution for x that will reasonably peak at and
be symmetric near 0.5 for any of these housekeeping genes under the
ideal states without “within-library” variability if we believe that its
expression is relatively stable—not differentially expressed between
normal and cancers. However, “within-library” variability is inevitable
when we considered about sampling, the initial contents and quality
of mRNA for each library, minimal physiological alterations and other
technical factors. So we deﬁned a cutoff value (for example, 0.90) into
the current Bayesianmodel for individual housekeeping gene normal-
ization, whichmeans that the probability of differential expression for
a gene at a speciﬁc F between pools is less than 0.10. We ﬁrst
determined an appropriate c value tomaintain a greater concentration
of x near 0.5 by setting c=0.5, 1, 1.5, 2, 2.5…, and then deﬁned the
minimal F (greater than or equal to 1) to maintain the acceptable
speciﬁcity by setting F=1, 2, 3, 4…. Thus, we could readily identify a
set of c and F combination for each housekeeping gene in the Bayesian
model (Fig. 1). We ﬁnally calculated the geometric averaging of c or F
values of all housekeeping genes between different pools and utilized
the combination of c and F geometric mean as the ﬁnal statistical
model for global identiﬁcation of candidate genes.
Datasets
Three common human cancers of lung, breast and colorectum,
were chosen in this study. Non-normalized SAGE pools of human
cancer bulk tissue and matched normal bulk tissue were down-
loaded from SAGE database [http://cgap.nci.nih.gov/SAGE]. These
SAGE Genie's libraries contained human lung (Lung normal B1;
Lung adenocarcinoma MD L9; Lung adenocarcinoma B1; Lung
adenocarcinoma MD L10), breast (Breast_normal_ epitheliu-
m_AP_Br_N; Breast_carcinoma_epithelium_AP_DCIS-2), and colon
(Colon_normal _B_NC1; Colon_normal_B_NC2; Colon_ adenocarci-
noma_B_Tu102; Colon_ adenocarcinoma_B_Tu98). A SAGE tag-gene
transcript mapping was done by SAGEMap which is on the basis of
matching SAGE data to tags extracted from Expressed Sequence Tag
(EST) and cDNA sequences in the NCBI UniGene clusters [32]. About
10%–23% of the tag-UniGene pairs in the full tag-to-gene mapping
might be entirely due to sequencing error. These error tags are not
represented by ESTs or cDNAs in GenBank. On the other hand, a
single tag mapping to multiple clusters was assigned as ambiguous.
Both tags were removed before the following EDGES analysis.
To observe the possible application of EDGES in data of different
source, we also downloaded human colorectal normal, adenoma and
cancer associated ESTs from dbEST (May 2005 release) [http://www.
ncbi.nlm.nih.gov/projects/dbEST/] and clustered them into UniGene
transcripts by using an EST-based pipeline in our previous study [33].
There were 20,370, 1270 and 279,163 ESTs, or 10,458, 875 and ﬁnally
200,608 UniGene transcripts (build#181) in colorectal normal,
adenoma and cancer pools, respectively. Approximately 20% ESTs
that failed to be clustered into Unigene transcripts were associated
with possible sequencing error and genomic DNA remnant, thus were
not included in further analysis.
Microarray analysis
The gene expression data of Affymetrix GeneChip Human Genome
U133 Plus 2.0 or U133A Array in human lung cancer, breast cancer, and
colorectal cancer and their matched normal tissue were downloaded
from the Gene Expression Omnibus repository [http://www.ncbi.
nlm.nih.gov/sites/entrez]. These datasets contained human lung
cancer (GSE7670, Affymetrix Human Genome U133A Array), breast
cancer (GSE7904, Affymetrix Human Genome U133 Plus 2.0 Array),
colorectal cancer (GSE4183, Affymetrix Human Genome U133 Plus 2.0Array) and their matched normal tissues. These datasets were applied
previously in cancer research [34–36]. Microarray data were analyzed
by the software packages BRB Array Tools, developed by the Biometric
Research Branch of the US National Cancer Institute [http://linus.nci.
nih.gov/BRB-ArrayTools.html]. The comparison tools in BRB combines
an univariate two-sample T-test and permutation test (n=10,000) to
ﬁnd differentially expressed genes with probability of 80% and false
discoveries of no more than 10% between cancers and their normal
tissue.
Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
To further validate the differentially expressed genes identiﬁed by
EDGES, we applied quantitative real time reverse transcription PCR
(qRT-PCR) to detect polymeric immunoglobulin receptor (PIGR)
(NM_002644) expression in snap-frozen fresh tissues of 24 adeno-
carcinomas with individual-matched normal mucosa. This gene was
screened from the EDGES analysis of both SAGE and EST pools in
colorectal normal and cancer. In addition, down-regulation of KLF4
(Kruppel-like factor 4 (gut), NM_004235) in colorectal cancer and up-
regulation of REG4 (Regenerating islet-derived family, member 4,
NM_032044) were also validated in our previous studies [22,23].
Glyceraldehyde-3-phosphate dehydrogenase (GAPD) (NM_002046),
β-actin (ACTB) (NM 001101) and β-2-microbulin (B2M) (NM 004048)
were used as an internal controls. We selected only 3 most popular
calibrators rather than 12 here due to the limited mRNA quantity. All
primers were exon-spanning and designed by Oligo5.0 software.
Gene-speciﬁc primers were: PIGR 5′-GACCAACGGCGATACTCT-3′ 5′-
ACCCTGCTTCACTCCACAC-3′; GAPDH 5′-ACCACAGTCCATGCCATCAC-3′
5′-ACCACAGTCCATGCCATCAC-3′; BACT 5′-CTGGAACGGTGAAGGT-
GACA-3′ 5′-AAGGGACTTCCTGTAACAATGCA-3′; B2M 5′-TGCTGTCTCC-
ATGTTTGATGTATCT-3′ 5′-TCTCTGCTCCCCACCTCTAAGT-3′. Total RNA
was isolated by using the Qiagen Rneasy Mini Kit (Qiagen GmbH,
Hilden, Germany) and reverse-transcribed by using the High-Capacity
cDNA Archive Kit (Applied Biosystems, CA, U.S.A) as in our previous
study [22,23]. 0.4 μl aliquot of each cDNA, 0.4 μM forward and reverse
primers was added to SYBR(R) Premix Ex TaqTM (Perfect Real Time)
(TaKaRa Bio Inc., Japan) in a total volume of 25 μl. cDNA was ﬁrst
denatured at 95 °C for 10 s, then followed 40 cycles of 95 °C for 5 s,
60 °C for 15 s and 72 °C for 34 s, and ﬁnally elongated at 72 °C for
2 min. The omission of cDNA template was used as a negative control.
The ampliﬁcation was run in triplicate. The relative amount of each
target gene mRNA to reference genes was calculated as the average
2−Δ Ct where Δ Ct=Ct−Mean Ct (GAPDH, BACT, B2M). A non-
parameter Wilcoxon test was applied to measure statistical
signiﬁcance of the observed difference. The threshold of signiﬁcance
level was established at 0.05 (2-tailed).
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